EP Patent

EP1888510A2 — Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications

Assigned to University of North Carolina at Chapel Hill · Expires 2008-02-20 · 18y expired

What this patent protects

The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications.

USPTO Abstract

The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications.

Drugs covered by this patent

Patent Metadata

Patent number
EP1888510A2
Jurisdiction
EP
Classification
—
Expires
2008-02-20
Drug substance claim
No
Drug product claim
No
Assignee
University of North Carolina at Chapel Hill
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.